The recent identification of p300 as an epigenetic driver of cellular senescence and an active player in a class of neurodegenerative diseases, such as tauopathies, renders its in-depth elucidation a high priority to remedy a significant data gap23,36. This evidence concerns the gene EP300 and neurodegenerative disease.